Compare Nvidia Corp (NVDA) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nvidia Corp vs Tenet Healthcare Corporation — how do they compare? Nvidia Corp trades at $218.2 (market cap $5.27T), while Tenet Healthcare Corporation trades at $260.39 (market cap $20.93B). The key difference: Nvidia Corp is far larger — about 251.8× Tenet Healthcare Corporation's market cap, and Nvidia Corp pays a 0.46% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| NVDA | THC | |
|---|---|---|
Market Cap | $5.27T | $20.93B |
Sector | Technology | Health |
52-Week High | $235.75 | $262.63 |
52-Week Low | $165.17 | $161.37 |
Enterprise Value | $5.20T | $32.01B |
Dividend Yield | 0.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NVIDIA (NVDA) trades at $217.48, down 2.89% on the day, with strong fundamentals including a 55.84% net income margin and 114.29% ROE. The stock shows a bullish technical trend, supported by moving averages, and has consistently beaten earnings expectations. Recent news highlights AI-driven growth potential, though some articles caution about valuation and market rotation.
Outlook remains positive with a consensus price target of $325.86, implying significant upside. Key opportunities include leadership in AI chips and robust financials, while risks involve high valuation multiples, competition, and macroeconomic sensitivity. The stock presents a growth opportunity tempered by execution and market risks.
Tenet Healthcare (THC) trades at $262.13, up 2.14% with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with Q2 2026 EPS beating estimates at $6.12 versus $4.26 expected, while valuation metrics remain attractive with P/E of 10.05 and EV/EBITDA of 5.74. Recent institutional buying and positive earnings revisions support the upward trend.
Outlook remains positive with consensus price target of $281.44 offering 7.4% upside potential. Key risks include healthcare policy headwinds and competitive pressures, but strong ambulatory growth and expense management provide fundamental support. The stock presents a compelling value-growth combination for investors seeking healthcare exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
